EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chemopreventive Effect of Bitter Melon (Momordica charantia) Juice on Pancreatic Carcinogenesis in LSL‐Kras G12D /+ ; p48 Cre/+ Mice

Lakshmi Sai Pratyusha Bugata, Deepanshi Dhar, Rama Kant iD, Robin Kumar, Md Imtiazul Kabir, Chapla Agarwal iD, Rajesh Agarwal iD, Komal Raina iD

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2026. Verfasst von Lakshmi Sai Pratyusha Bugata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, South Dakota State University, Brookings, South Dakota, USA. Hauptthemen laut MEDLINE: Momordica charantia, Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Carcinoma, Pancreatic Ductal. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, using the LSL‐Kras G12D/+ ; p48 Cre/+ transgenic mouse model [that recapitulates the full spectrum of human disease, progressing from early pancreatic intraepithelial neoplasia lesions to invasive pancreatic ductal adenocarcinoma (PDAC)], we determined the chemopreventive effect of long‐term (chronic) administration of Bitter Melon Juice (BMJ‐standardized lyophilized juice processed from the fruits of Momordica charantia ) against pancreatic cancer. Starting at 6 weeks of age, female LSL‐Kras G12D/+ ; p48 Cre/+ mice were subjected to BMJ intervention (oral gavage, dose: 200 mg/kg body wt., 5 days/week) for 35 weeks (study end: 41 weeks of age), and pathological and molecular changes in the pancreas were assessed. Results indicated that BMJ shifted the pancreatic tumor profile from moderately differentiated adenocarcinoma in controls towards a more heterogeneous profile enriched for well‐differentiated lesions indicating that prolonged exposure to BMJ bioactives results in a less aggressive phenotype. BMJ significantly reduced proliferative index (~24%) and induced a ~ 4‐fold increase in apoptosis in the pancreas. The effects on AMPK activation (~2‐fold increase) and decrease in the expression of [glucose (GLUT‐1) and lactate (MCT‐4) transporter levels (∼49%–69%,), NF‐κB/p65 (~40%), EMT marker‐Vimentin (~46%), fibrotic microenvironment marker (α‐SMA, ~29%) and Mucin‐1 (MUC‐1, ~45%)] indicate that BMJ modulates several interconnected pathways essential for PDAC growth and progression. Plasma proteomic profiling indicated that Fractalkine (CX3CL1), MIP‐3β (CCL19), MIP‐3α (CCL20), and SCF were decreased by BMJ, while Axl and TNF‐alpha were overexpressed in BMJ‐treated animals compared to positive controls. These results encourage further research into bitter melon compounds as a potential chemopreventive option for pancreatic cancer, especially for high‐risk groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Momordica charantiaPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Carcinoma, Pancreatic DuctalPlant ExtractsCarcinogenesisAnimalsMiceFemaleMice, TransgenicDisease Models, AnimalHumansPancreas

Stichwörter der Autor:innen

KrasG12D/+ modelMomordica charantiabitter meloncancer preventionpancreatic cancerpancreatic ductal adenocarcinoma

Substanzen

Proto-Oncogene Proteins p21(ras)Plant ExtractsHras protein, mouse

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, South Dakota State University, Brookings, South Dakota, USA.
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Rama Kant, Chapla Agarwal, Rajesh Agarwal, Komal Raina

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bugata, L. S. P., Dhar, D., Kant, R., Kumar, R., Kabir, M. I., Agarwal, C., Agarwal, R., & Raina, K. (2026). Chemopreventive Effect of Bitter Melon (Momordica charantia) Juice on Pancreatic Carcinogenesis in LSL‐Kras G12D /+ ; p48 Cre/+ Mice. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70164

Vancouver

Bugata LSP, Dhar D, Kant R, Kumar R, Kabir MI, Agarwal C, et al. Chemopreventive Effect of Bitter Melon (Momordica charantia) Juice on Pancreatic Carcinogenesis in LSL‐Kras G12D /+ ; p48 Cre/+ Mice. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70164

BibTeX
@article{Bugata2026,
  author = {Bugata, Lakshmi Sai Pratyusha and Dhar, Deepanshi and Kant, Rama and Kumar, Robin and Kabir, Md Imtiazul and Agarwal, Chapla and Agarwal, Rajesh and Raina, Komal},
  title = {Chemopreventive Effect of Bitter Melon (Momordica charantia) Juice on Pancreatic Carcinogenesis in LSL‐Kras G12D /+ ; p48 Cre/+ Mice},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70164}
}
Kostenlos starten →